Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.62
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM
3.62
0.00%
After-hours: Aug 20, 2025, 07:59 PM EDT

Altimmune Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-95.06M -88.45M -84.71M -97.09M
Depreciation & Amortization
238K 477K 493K 551K
Stock-Based Compensation
14.39M 10.64M 8.1M 5.52M
Other Working Capital
4.6M -3.23M 8.04M -8.21M
Other Non-Cash Items
-3.9M 9.79M -578K 700.61K
Deferred Income Tax
n/a n/a n/a 12.33M
Change in Working Capital
4.48M -8.27M 14.11M -251K
Operating Cash Flow
-79.85M -75.81M -62.59M -78.24M
Capital Expenditures
n/a -47K -126K -12.31M
Cash Acquisitions
n/a n/a n/a 194.54K
Purchase of Investments
-115.73M -88.63M -73.27M -7.59M
Sales Maturities Of Investments
87.34M 102.41M n/a 107.43M
Other Investing Acitivies
n/a n/a n/a -389.29K
Investing Cash Flow
-28.39M 13.73M -73.4M 87.52M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
50K -711K 434K 58K
Financial Cash Flow
10.04M 86.11M 56.78M 65.1M
Net Cash Flow
-98.19M 24.03M -79.2M 74.38M
Free Cash Flow
-79.85M -75.86M -62.71M -90.55M